PURPOSE: This study aimed to determine the composition and diversity of bacterial communities on the ocular surface before and after the intervention with sodium hyaluronate eye drops (with or without preservatives) using 16S rRNA gene amplicon sequencing.
METHODS: Sixteen healthy adults were randomly divided into two groups and treated with sodium hyaluronate eye drops with or without preservatives for 2 weeks. The individuals used the same artificial tears in both eyes. The microbial samples from the conjunctival sac of each participant were collected at baseline and 2 weeks after intervention. The diversity and taxonomic differences among different groups before and after intervention were compared by sequencing the V3-V4 region of the 16S rRNA gene.
RESULTS: The similarity in the binocular microbial community was high in 1 of the 16 volunteers (Bray-Curtis dissimilarity score < 0.3). At the genus level, 11 bacteria were detected in all samples with an average relative abundance of more than 1%. The bacterial community changed significantly after the use of sodium hyaluronate eye drops (with or without preservatives), whether within individuals or between individuals in different groups ( < 0.05, PERMANOVA). Different dosage forms of sodium hyaluronate eye drops significantly decreased the relative abundance of and , respectively ( < 0.05).
CONCLUSIONS: Healthy people had a rich diversity of the bacterial microbiota on the ocular surface, but the bacterial communities between the eyes were not completely similar. Irrespective of containing benzalkonium chloride (BAC), sodium hyaluronate eye drops can change the bacterial community on the ocular surface.
Curr Eye Res. 2019 Jul;44(7):685-694
[PMID:
30640553]
Invest Ophthalmol Vis Sci. 1993 Jun;34(7):2313-5
[PMID:
8505213]
Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5408-13
[PMID:
21571682]
Bioinformatics. 2011 Nov 1;27(21):2957-63
[PMID:
21903629]
Optometry. 2011 Jan;82(1):38-43
[PMID:
21146792]
Br J Ophthalmol. 2004 Jun;88(6):821-5
[PMID:
15148219]
Eye (Lond). 1998;12 ( Pt 5):829-33
[PMID:
10070519]
J Ocul Pharmacol Ther. 2004 Dec;20(6):548-53
[PMID:
15684813]
J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):591-4
[PMID:
23442006]
Prog Retin Eye Res. 2010 Jul;29(4):312-34
[PMID:
20302969]
Microorganisms. 2019 Aug 14;7(8):
[PMID:
31416201]
Bioinformatics. 2011 Aug 15;27(16):2194-200
[PMID:
21700674]
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6030-6037
[PMID:
29196767]
Transl Vis Sci Technol. 2018 Nov 30;7(6):16
[PMID:
30519501]
Front Med (Lausanne). 2020 Nov 04;7:592759
[PMID:
33251239]
Ocul Surf. 2019 Jan;17(1):111-118
[PMID:
30445178]
Genome Biol. 2013 Jan 14;14(1):R1
[PMID:
23316946]
Clin Microbiol Infect. 2016 Jul;22(7):643.e7-643.e12
[PMID:
27102141]
Nat Methods. 2013 Oct;10(10):996-8
[PMID:
23955772]
PLoS One. 2011;6(10):e26103
[PMID:
22022526]
Int J Ophthalmol. 2019 Feb 18;12(2):194-200
[PMID:
30809472]
J Mater Sci Mater Med. 2011 Oct;22(10):2329-38
[PMID:
21892787]
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
[PMID:
17586664]
Bioinformatics. 2018 Sep 1;34(17):i884-i890
[PMID:
30423086]
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4774-4783
[PMID:
31738825]
Nucleic Acids Res. 2007;35(21):7188-96
[PMID:
17947321]
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):47
[PMID:
32106294]
Adv Ther. 2006 Nov-Dec;23(6):835-41
[PMID:
17276951]
Ocul Surf. 2019 Apr;17(2):265-271
[PMID:
30742990]
Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1681-7
[PMID:
21842132]
Nature. 2007 Oct 18;449(7164):804-10
[PMID:
17943116]
J Microbiol. 2019 Nov;57(11):1025-1032
[PMID:
31463790]
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5116-5126
[PMID:
27699405]
Genome Med. 2014 Nov 15;6(11):99
[PMID:
25484919]
Sci Rep. 2017 Aug 29;7(1):9880
[PMID:
28852195]
Acta Ophthalmol. 2021 Feb;99(1):16-25
[PMID:
32602257]
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
[PMID:
16332807]
Nat Methods. 2013 Jan;10(1):57-9
[PMID:
23202435]
mBio. 2016 Mar 22;7(2):e00198
[PMID:
27006462]
Eur J Ophthalmol. 2007 May-Jun;17(3):341-9
[PMID:
17534814]
Ocul Surf. 2017 Jul;15(3):276-283
[PMID:
28736335]
Acta Ophthalmol Scand. 1996 Dec;74(6):566-8
[PMID:
9017043]
J Ophthalmol. 2020 Apr 17;2020:1780498
[PMID:
32377412]
Nat Methods. 2010 May;7(5):335-6
[PMID:
20383131]
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):35
[PMID:
32543662]
Ocul Surf. 2020 Oct;18(4):706-712
[PMID:
32717380]
Int J Mol Sci. 2017 Jun 29;18(7):
[PMID:
28661456]
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):128-136
[PMID:
28114568]
